| P50 | author | Michael R Doschak | Q44801378 |
| | Krishna Hari Bhandari | Q57008664 |
| P2093 | author name string | Lili Tang | |
| | Mavanur Suresh | |
| | Madhuri Newa | |
| | Rohit Kalvapalle | |
| P2860 | cites work | Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1 | Q22306225 |
| | Peptides from the calcitonin genes: molecular genetics, structure and function | Q24528188 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Osteoclasts: what do they do and how do they do it? | Q24683898 |
| | Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 |
| | Tissue sulfhydryl groups | Q26778486 |
| | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| | The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 |
| | Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function | Q28274181 |
| | RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis | Q28293009 |
| | Intracellular machinery for matrix degradation in bone-resorbing osteoclasts | Q28573302 |
| | Osteoclast differentiation and activation | Q29547556 |
| | Isolation, characterization, and stability of positional isomers of mono-PEGylated salmon calcitonins | Q30632211 |
| | Synthesis, characterization and in vitro evaluation of a bone targeting delivery system for salmon calcitonin | Q33562410 |
| | The cell biology of osteoclast function. | Q33819720 |
| | Sex steroids and the construction and conservation of the adult skeleton | Q34131889 |
| | Emerging protein delivery methods | Q34208167 |
| | Methyl 4-mercaptobutyrimidate as a cleavable crosslinking reagent and its application to the Escherichia coli 30S ribosome | Q34213591 |
| | Tartrate-resistant acid phosphatase as a serum marker of bone resorption. | Q34323649 |
| | Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS. | Q34628768 |
| | Characterization of specific receptors for calcitonin in porcine lung | Q35390617 |
| | RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini | Q35641868 |
| | Pharmacokinetic consequences of pegylation | Q36604526 |
| | Advances in bone biology: the osteoclast | Q36825193 |
| | Osteoclast lineage and function | Q37142835 |
| | A rapid point of care immunoswab assay for SARS-CoV detection | Q37184045 |
| | Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women | Q37610411 |
| | Do RANKL inhibitors (denosumab) affect inflammation and immunity? | Q37767159 |
| | c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation | Q39741079 |
| | Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling | Q40279586 |
| | Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens. | Q40454982 |
| | Expression and function of TNF-family proteins and receptors in human osteoblasts. | Q40616037 |
| | Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin | Q40837367 |
| | Addition of sulfhydryl groups of Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate) | Q40975811 |
| | Esophagitis associated with the use of alendronate | Q41102881 |
| | Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis | Q44209334 |
| | The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K. | Q44788394 |
| | Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption | Q45840265 |
| | Size comparison between proteins PEGylated with branched and linear poly(ethylene glycol) molecules | Q47290801 |
| | Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. | Q50335960 |
| | The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 |
| | Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man | Q67018064 |
| | Effect of elcatonin on osteoinduction by recombinant human bone morphogenetic protein-2 | Q73525114 |
| | Solution stability of salmon calcitonin at high concentration for delivery in an implantable system | Q73718169 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 5 | |
| P304 | page(s) | 1131-1143 | |
| P577 | publication date | 2011-02-08 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Antibody-mediated "universal" osteoclast targeting platform using calcitonin as a model drug | |
| P478 | volume | 28 | |